炎症性肌纤维细胞瘤从分子诊断到当前的治疗
Paulina Chmiel1,2, Aleksandra SłOWIKOWSKA1,2, Łukasz Banaszek1,2
1Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, 02-781, Poland.
Oncology research
|July 1, 2024
概括
炎症性肌纤维细胞瘤 (IMT) 是一种罕见的癌症. 本综述涵盖了ALK基因融合,像crizotinib这样的向疗法,以及新兴的免疫疗法,以获得更好的治疗策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 炎症性肌纤维细胞瘤 (IMT) 是一种罕见的新生体,具有中间恶性病变.
- 由于呈现和成像特征的多样性,诊断具有挑战性.
- 无性淋巴瘤激酶 (ALK) 基因融合是IMT病例70%的关键诊断和治疗标.
研究的目的:
- 审查目前关于IMT的研究,重点关注遗传改变.
- 分析向治疗方案和免疫疗法潜力.
- 总结预后因素和抵抗机制.
主要方法:
- 关于IMT研究的文献综述.
- 对遗传变化的分析,包括ALK融合.
- 对向疗法 (如crizotinib) 和免疫疗法进行评估.
主要成果:
- ALK基因融合对于IMT诊断和向治疗至关重要.
- 克里佐替尼被FDA批准用于ALK重组的IMT,但耐药性很常见.
- 联合放射疗法和向疗法显示出有前途;免疫疗法正在出现.
结论:
- 优化高级IMT治疗需要了解遗传驱动因素和耐药性.
- 连续治疗,包括放射治疗和免疫治疗,对于持续的反应至关重要.
- 需要进一步的研究来制定最终的治疗建议.
更多相关视频
07:21Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
2.0K
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11.5K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
